Pharmacological profile of a new anti-lipolytic agent: 5-methyl-pyrazine-2-carboxylic acid 4-oxide (acipimox) I — Mechanism of action
- 1 February 1981
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 13 (2) , 151-161
- https://doi.org/10.1016/s0031-6989(81)80016-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- THE COLORIMETRIC DETERMINATION OF PHOSPHORUSPublished by Elsevier ,2021
- A New Perspective on Cholesterol Metabolism in ManPerspectives in Biology and Medicine, 1975
- A simple direct assay for cyclic amp in plasma and other biological samples using an improved competitive protein binding techniqueClinica Chimica Acta; International Journal of Clinical Chemistry, 1974
- Synthesis of cholesterol in hypercholesterolemia and its relationship to plasma triglyceridesMetabolism, 1973
- Antagonistic action of metabolic inhibitors on dibutyryl cyclic 3′5′-adenosine monophosphate-stimulated and caffeine-stimulated lipolysis in vitroLife Sciences, 1967
- Acute Effects of Nicotinic Acid in the RatActa Medica Scandinavica, 1966
- γ-Hydroxybutyrate in Mammalian BrainPublished by Elsevier ,1964
- A RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND THE METABOLISM OF GLUCOSEJournal of Clinical Investigation, 1956